Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02808338 · ClinicalTrials.gov registry record · NA
Servo-Ventilation In-lab PSG Evaluation
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02808338 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 25 participants.
The verdict
NCT02808338, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Continuous Positive Airway Pressure (CPAP) is the most effective treatment for the Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS). CPAP stabilizes the airway and prevents instability and collapse. With a stable and patent airway, breathing continues in a normal manner, gas exchange is improved, and there is no disruption of sleep related to disturbed breathing. Auto Servo Ventilation (Auto SV) is a mode of positive airway pressure used to treat obstructive and complex central sleep apnea. The main features of the Auto SV mode include: * Normalization of ventilation by automatically adjusting Inspiratory Positive Airway Pressure (IPAP) pressure to achieve a target ventilation. IPAP is increased or decreased to help stabilize the ventilation. * Provision of timed, back-up breaths during central apneas. The optimal back-up rate is automatically determined by the device based on the patient's breathing. * Automatic control of Expiratory Positive Airway Pressure (EPAP) to treat obstructive events. Several manufacturers produce these types of devices. The algorithms used to determine the IPAP, EPAP and minimum respiratory rate are different. The largest number of these devices currently in use are the BiPAP AutoSV Advanced System One (Philips Respironics, Murrysville PA) and the Variable positive airway pressure (VPAP) Adapt (ResMed Corp., San Diego CA).
Interventions
- DEVICE Philips BiPAP AutoSV Advanced System One
- DEVICE Modified Philips BiPAP ASV
- DEVICE ResMed S7 VPAP Adapt
- DEVICE ResMed S9 VPAP Adapt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-11-09 |
| Est. Completion | 2017-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02808338
The ClinicalTrials.gov registry entry for NCT02808338 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Philips BiPAP AutoSV Advanced System One is the first listed.
NCT02808338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02808338 about?
NCT02808338 is a clinical study titled "Servo-Ventilation In-lab PSG Evaluation". Continuous Positive Airway Pressure (CPAP) is the most effective treatment for the Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS). CPAP stabilizes the airway and prevents instability and collapse. With a stable and patent airway, breathing continues in a normal manner, gas exchange is improved, a...
What is the current status of trial NCT02808338?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2015-11-09. Estimated completion is 2017-07-06.
What interventions are being tested in trial NCT02808338?
The interventions under investigation include: Philips BiPAP AutoSV Advanced System One (DEVICE), Modified Philips BiPAP ASV (DEVICE), ResMed S7 VPAP Adapt (DEVICE), ResMed S9 VPAP Adapt (DEVICE).
Who is sponsoring clinical trial NCT02808338?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.